Kifa Therapeutics
PrivateLast Round
Seed
Mar 18, 2026
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Kifa Therapeutics is a precision neuroscience company developing first-in-class, mutant-selective small-molecule therapies for genetically defined Parkinson's disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kifa Therapeutics Comparables
Compare Kifa Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neuron23 | 81% | |
| Brenig Therapeutics | 81% | |
| Denali Therapeutics | 74% | |
Kifa Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 18, 2026 |
Kifa Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Tennessee Technology Development Corporation | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 18, 2026
$8M round with Tennessee Technology Development Corporation
Kifa Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Kifa Therapeutics's valuation, stock price, and market status.